167 related articles for article (PubMed ID: 24356586)
1. Adenovirus vectors lacking virus-associated RNA expression enhance shRNA activity to suppress hepatitis C virus replication.
Pei Z; Shi G; Kondo S; Ito M; Maekawa A; Suzuki M; Saito I; Suzuki T; Kanegae Y
Sci Rep; 2013 Dec; 3():3575. PubMed ID: 24356586
[TBL] [Abstract][Full Text] [Related]
2. [Recent progress in adenovirus vectors: focusing on VA-deleted AdV].
Kondo S; Maekawa A; Saito I; Kanegae Y
Uirusu; 2013; 63(2):155-64. PubMed ID: 25366050
[TBL] [Abstract][Full Text] [Related]
3. Efficient production of adenovirus vector lacking genes of virus-associated RNAs that disturb cellular RNAi machinery.
Maekawa A; Pei Z; Suzuki M; Fukuda H; Ono Y; Kondo S; Saito I; Kanegae Y
Sci Rep; 2013; 3():1136. PubMed ID: 23355950
[TBL] [Abstract][Full Text] [Related]
4. An adenovirus type 5 (Ad5) amplicon-based packaging cell line for production of high-capacity helper-independent deltaE1-E2-E3-E4 Ad5 vectors.
Catalucci D; Sporeno E; Cirillo A; Ciliberto G; Nicosia A; Colloca S
J Virol; 2005 May; 79(10):6400-9. PubMed ID: 15858023
[TBL] [Abstract][Full Text] [Related]
5. Improving adenovirus vector-mediated RNAi efficiency by lacking the expression of virus-associated RNAs.
Machitani M; Sakurai F; Katayama K; Tachibana M; Suzuki T; Matsui H; Yamaguchi T; Mizuguchi H
Virus Res; 2013 Dec; 178(2):357-63. PubMed ID: 24055658
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of hepatitis C virus infection and expression in vitro and in vivo by recombinant adenovirus expressing short hairpin RNA.
Sakamoto N; Tanabe Y; Yokota T; Satoh K; Sekine-Osajima Y; Nakagawa M; Itsui Y; Tasaka M; Sakurai Y; Cheng-Hsin C; Yano M; Ohkoshi S; Aoyagi Y; Maekawa S; Enomoto N; Kohara M; Watanabe M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1437-47. PubMed ID: 17683479
[TBL] [Abstract][Full Text] [Related]
7. A simple method for constructing E1- and E1/E4-deleted recombinant adenoviral vectors.
Mizuguchi H; Kay MA
Hum Gene Ther; 1999 Aug; 10(12):2013-7. PubMed ID: 10466635
[TBL] [Abstract][Full Text] [Related]
8. Generation of an adenovirus vector lacking E1, e2a, E3, and all of E4 except open reading frame 3.
Gorziglia MI; Lapcevich C; Roy S; Kang Q; Kadan M; Wu V; Pechan P; Kaleko M
J Virol; 1999 Jul; 73(7):6048-55. PubMed ID: 10364357
[TBL] [Abstract][Full Text] [Related]
9. [Development of Novel Genetically Engineered Adenoviruses Based on Functional Analyses of Adenovirus-encoded Small RNAs].
Machitani M
Yakugaku Zasshi; 2016; 136(11):1509-1515. PubMed ID: 27803482
[TBL] [Abstract][Full Text] [Related]
10. Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement.
Ji L; Bouvet M; Price RE; Roth JA; Fang B
Gene Ther; 1999 Mar; 6(3):393-402. PubMed ID: 10435089
[TBL] [Abstract][Full Text] [Related]
11. Development of an adenovirus vector lacking the expression of virus-associated RNAs.
Machitani M; Katayama K; Sakurai F; Matsui H; Yamaguchi T; Suzuki T; Miyoshi H; Kawabata K; Mizuguchi H
J Control Release; 2011 Sep; 154(3):285-9. PubMed ID: 21703313
[TBL] [Abstract][Full Text] [Related]
12. Effects of first generation E1E3-deleted and second generation E1E3E4-deleted/modified adenovirus vectors on human endothelial cell death.
Jornot L; Petersen H; Lusky M; Pavirani A; Moix I; Morris ; Rochat T
Endothelium; 2001; 8(3):167-79. PubMed ID: 11824470
[TBL] [Abstract][Full Text] [Related]
13. Stable replication of the EBNA1/OriP-mediated baculovirus vector and its application to anti-HCV gene therapy.
Suzuki H; Matsumoto N; Suzuki T; Chang MO; Takaku H
Virol J; 2009 Oct; 6():156. PubMed ID: 19796392
[TBL] [Abstract][Full Text] [Related]
14. A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4.
Brough DE; Lizonova A; Hsu C; Kulesa VA; Kovesdi I
J Virol; 1996 Sep; 70(9):6497-501. PubMed ID: 8709289
[TBL] [Abstract][Full Text] [Related]
15. Adenovirus-encoding virus-associated RNAs suppress HDGF gene expression to support efficient viral replication.
Kondo S; Yoshida K; Suzuki M; Saito I; Kanegae Y
PLoS One; 2014; 9(9):e108627. PubMed ID: 25275311
[TBL] [Abstract][Full Text] [Related]
16. In vitro characterization of the activity of PF-05095808, a novel biological agent for hepatitis C virus therapy.
Lavender H; Brady K; Burden F; Delpuech-Adams O; Denise H; Palmer A; Perkins H; Savic B; Scott S; Smith-Burchnell C; Troke P; Wright JF; Suhy D; Corbau R
Antimicrob Agents Chemother; 2012 Mar; 56(3):1364-75. PubMed ID: 22203606
[TBL] [Abstract][Full Text] [Related]
17. Safe, long-term hepatic expression of anti-HCV shRNA in a nonhuman primate model.
Suhy DA; Kao SC; Mao T; Whiteley L; Denise H; Souberbielle B; Burdick AD; Hayes K; Wright JF; Lavender H; Roelvink P; Kolykhalov A; Brady K; Moschos SA; Hauck B; Zelenaia O; Zhou S; Scribner C; High KA; Renison SH; Corbau R
Mol Ther; 2012 Sep; 20(9):1737-49. PubMed ID: 22735378
[TBL] [Abstract][Full Text] [Related]
18. Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants.
Krougliak V; Graham FL
Hum Gene Ther; 1995 Dec; 6(12):1575-86. PubMed ID: 8664382
[TBL] [Abstract][Full Text] [Related]
19. Suppression of hepatitis B virus antigen production and replication by wild-type HBV dependently replicating HBV shRNA vectors in vitro and in vivo.
Li B; Sun S; Li M; Cheng X; Li H; Kang F; Kang J; Dörnbrack K; Nassal M; Sun D
Antiviral Res; 2016 Oct; 134():117-129. PubMed ID: 27591142
[TBL] [Abstract][Full Text] [Related]
20. Construction and characterization of E1-minus replication-defective adenovirus vectors that express E3 proteins from the E1 region.
Toth K; Kuppuswamy M; Doronin K; Doronina O; Lichtenstein D; Tollefson A; Wold W
Virology; 2002 Sep; 301(1):99-108. PubMed ID: 12359450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
